Premium
Central Administration of Hydrogen Sulfide Alleviates Rodent Angiotensin II Hypertension
Author(s) -
Donertas Basak,
Malphurs Wendi L.,
Baekey David M.,
Julian David,
Sirmagul Basar,
Zubcevic Jasenka
Publication year - 2019
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2019.33.1_supplement.835.18
Subject(s) - sodium hydrosulfide , saline , medicine , angiotensin ii , endocrinology , endogeny , blood pressure , renin–angiotensin system , mean arterial pressure , hydrogen sulfide , chemistry , heart rate , sulfur , organic chemistry
Activation of autonomic neural pathways plays a significant role in pathogenesis of hypertension (HTN). Hydrogen sulfide (H 2 S) is an endogenous neuro‐ and immunomodulatory molecule that is reportedly reduced in both rodent and human HTN. However, central role of H 2 S in HTN is not well understood. We hypothesized that chronic intracerebroventricular (ICV) infusion of sodium hydrosulfide (NaHS), an H 2 S donor, will alleviate rodent angiotensin II (Ang II) HTN. Methods Adult male Sprague Dawley rats were implanted with radiotelemetry transmitters (DSI) in the descending aorta. Following baseline BP measurements, rats were randomly divided into three groups: (i) ICV NaHS; (ii) HTN; and (iii) ICV NaHS‐treated HTN rats. HTN was induced by chronic infusion of Ang II (200 ng/kg/min s.c.) for four weeks using mini‐osmotic pumps. ICV NaHS (30 nmol/h) or ICV saline was administered simultaneously with s.c. Ang II or saline infusion. At endpoint, H 2 S levels were measured in plasma samples of all rats. Results At week four, mean arterial pressure (MAP) was significantly reduced in the ICV NaHS‐treated HTN group when compared with HTN group (104±7 vs. 166±5 mmHg, respectively; P< 0.01). This was associated with a lower MAP at night in the ICV NaHS‐treated HTN vs. HTN group (Delta MAP from day to night: 15.29±4 vs. 31.37±17 mmHg, respectively), suggesting reduced sympathetic drive following treatment with NaHS. Interestingly, this also reflected in significantly higher plasma H 2 S levels in the ICV NaHS‐treated HTN vs. HTN group (0.070±0.000 AU vs. 0.067±0.000 AU, respectively; P<0.05). Conclusion These results support our hypothesis that alterations in central H 2 S signaling are associated with HTN, as centrally administered NaHS alleviated rodent Ang II HTN via reduction of sympathetic tone at night. Support or Funding Information TUBITAK 2214‐A and UF CVM. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .